RIP, Craig Venter

quote:

---

The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died today in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer.

Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, and insisting that discovery should translate into real-world impact. He was also a fierce advocate for robust federal science funding and for partnerships that accelerate progress across government, academia, and industry.

“Craig believed that science moves forward when people are willing to think differently, move decisively, and build what doesn’t yet exist,” said Anders Dale, president of JCVI. “His leadership and vision reshaped genomics and helped ignite synthetic biology. We will honor his legacy by continuing the mission he built—advancing genomic science, championing the public investments that make discovery possible, and partnering broadly to turn knowledge into impact.”

Across his career, Dr. Venter helped move genomics from slow, gene-by-gene discovery to scalable, data-driven science—and then helped take the next step: demonstrating that genomes could be designed and constructed.

At the National Institutes of Health, he helped pioneer gene discovery using expressed sequence tags (ESTs), enabling rapid identification of large numbers of human genes and accelerating genome mapping efforts.

He went on to lead efforts that produced the first draft sequences of the human genome, a milestone that helped usher biology into the digital age. He and colleagues later published the first high-quality diploid human genome, demonstrating the importance of capturing genetic variation inherited from both parents.

In synthetic biology, Dr. Venter and his teams achieved a landmark by constructing the first self-replicating bacterial cell controlled by a chemically synthesized genome—proof that genomes could be designed digitally, built from chemical components, and “booted up” to run a living cell.

He also pursued scientific discovery at global scale. Through the Sorcerer II Global Ocean Sampling Expedition, Dr. Venter and his teams used metagenomics to reveal extraordinary microbial diversity, reporting the discovery of millions of new genes and expanding the known universe of protein families—work that deepened understanding of the ocean microbiome and its role in planetary systems.

Beyond his scientific achievements, Dr. Venter was a builder: of teams, platforms, and institutions designed to take big scientific bets. In addition to founding JCVI, he was a serial entrepreneur who co-founded Synthetic Genomics, Inc., Human Longevity, Inc., and most recently Diploid Genomics, Inc., advancing efforts to translate genomics and synthetic biology into tools for health and society.

---

Venter Institute

quote:

---

In 2000, his company, Celera, made a joint announcement with a rival group saying that they had assembled the first human genomes, a landmark step toward uncovering the genetic basis of human disease and origins.

---

And in 2026, Element Biosciences, a firm in San Diego, introduced a new product that maps the human genome in seconds using at its core, a first of its kind sensor technology so precise that it can focus and capture live video of objects as tiny as 2 nanometers wide—roughly 50,000 times thinner than the width of a typical human hair. I brought this technology to them as soon as I was aware from trade journals of what they were trying to accomplish with a competing product that I knew could never get them where they needed to be. It was so important to my employer that Element Bios succeed in making this work out that we dedicated one of our senior engineers, at no cost to them, for four months to make this product work. With it, and AI, they can now fully map out a person's entire genome for under $100.

The importance and opportunity were very clear, and an NDA prevented me from ever discussing it until it became a publicly announced product, but with this new product bringing the cost down to basically a lab fee it will lead to every pharmacy, every research hospital and every lab site around the world using these devices along with AI to create individual specific pharmaceutical profiles that are designed to uniquely exploit each person's individual genome, which, coincidentally is the width of 2 nanometers and if uncoiled from a single cell it would be 6.5' in length with 3 billions pairs of DNA attached.

Press release: Element Bios

Now that is a name I have not heard in awhile. His company was working on making fuel from algae among other things if my memory serves me correctly. Trying to actually make via dna construction of a man made algae that makes fuel.

quote:

---

And in 2026, Element Biosciences, a firm in San Diego, introduced a new product that maps the human genome in seconds using at its core, a first of its kind sensor technology so precise that it can focus and capture live video of objects as tiny as 2 nanometers wide—roughly 50,000 times thinner than the width of a typical human hair. I brought this technology to them as soon as I was aware from trade journals of what they were trying to accomplish with a competing product that I knew could never get them where they needed to be. It was so important to my employer that Element Bios succeed in making this work out that we dedicated one of our senior engineers, at no cost to them, for four months to make this product work. With it, and AI, they can now fully map out a person's entire genome for under $100.

The importance and opportunity were very clear, and an NDA prevented me from ever discussing it until it became a publicly announced product, but with this new product bringing the cost down to basically a lab fee it will lead to every pharmacy, every research hospital and every lab site around the world using these devices along with AI to create individual specific pharmaceutical profiles that are designed to uniquely exploit each person's individual genome, which, coincidentally is the width of 2 nanometers and if uncoiled from a single cell it would be 6.5' in length with 3 billions pairs of DNA attached.

---

Whoa! So, like...are you going to be a billionaire now?

quote:

---

the detestable Francis Collins

Maybe it's just me, but I don't trust a man named "Francis" any more than I trust a woman named "Russell".

...with notable exception for the late Francis Scott Key, a true patriot from an era when "Francis" was actually a masculine name.

---

Francis from "Stripes" was pretty badass too.